Geneva reports have implications for dental providers.
Ritchie
J
J
Louisiana State University, School of Dentistry, Baton Rouge, LA.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000935:Antifungal Agents / Q000627:therapeutic use; D002180:Candidiasis, Oral / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D015725:Fluconazole / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D015497:HIV-1; D006801:Humans; D016273:Occupational Exposure; D009912:Oral Manifestations; D012367:RNA, Viral / Q000032:analysis; D012463:Saliva / Q000737:chemistry / Q000821:virology
D000935:Antifungal Agents; D012367:RNA, Viral; D015725:Fluconazole